Brief: Petros Pharmaceuticals - Qtrly Earnings Per Share Of $0.31
May 17 (Reuters) - Petros Pharmaceuticals Inc PTPI.O :
* PETROS PHARMACEUTICALS ANNOUNCES FIRST QUARTER FINANCIAL
RESULTS
AND PROVIDES CORPORATE UPDATE; REPORTS 300% INCREASE IN
YEAR-OVER-YEAR STENDRA NET SALES
* Q1 SALES $4.1 MILLION
* QTRLY EARNINGS PER SHARE 31 CENTS
Source text for Eikon: ID:nPn98Vk45a
Further company coverage: PTPI.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Petros Pharmaceuticals
See all newsBrief: Petros Pharmaceuticals Assigns All Assets To Pt Liquidation, For Benefit Of Creditors
Brief: Petros Pharmaceuticals’ STENDRA Pivotal Consumer Self-Selection Study for Over-the-Counter Access Demonstrates Statistical Significance
Brief: Petros Pharmaceuticals Files For Mixed Shelf Of Up To $100 Million - SEC Filing
Brief: Petros Pharmaceuticals Expands Online Distribution For Prescription STENDRA(R) Through New Agreement With Lemonaid Health
Brief: Petros Pharma Announces Partnership with Idea Evolver for Rx-to-OTC Switches & Digital Launch Solutions